Daily as of 3 Nov 16:00 ET
- Price
- between the two $229.74 vs 50 $230.67 / 200 $217.15
- Projection
- 💀Death cross estimated in 18 to 26 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 18 Sep 2025 · projected 28 bars out
JAZZ | Jazz PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$229.74
+$15.30 (+7.13%)
Jazz Pharmaceuticals (JAZZ) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Sep 2025, but the two have been closing on each other and a death cross is projected within 30 bars. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $215.98 vs 50 $208.58 / 200 $145.20
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 26 Jan 2026 · projected 23 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- between the two $230.42 vs 50 $218.19 / 200 $237.86
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 1 Oct 2026 · projected 16 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 1 Oct 2026 | 💀Death | 4-hour | 16 bars out | Not tested |
| week of 26 Jan 2026 | 🟨Golden moderate | weekly | 23 bars out | Not tested |
| 18 Sep 2025 | 🟨Golden steep | daily | 28 bars out | Not tested |
| 5 Aug 2025 | 🟨Golden | 4-hour | 29 bars out | — |
| 15 May 2025 | 💀Death steep | daily | 23 bars out | Not tested |
About JAZZ
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$164M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge